» CRYOcheck™ Heparin Control

HEMOSTASIS COAGULATION ROUTINE FROZEN CALIBRATORS AND CONTROLS SCREENING TEST CONTROLS

CRYOcheck™ Heparin Control

Fresh frozen plasmas

Pathological plasma for the assay of activated partial thromboplastin time (TCA) and anti-factor Xa.

CRYOcheck™Heparin Control is a hemostatic quality control made from a plasma pool that has been overloaded with sodium unfractionated heparins to monitor the change in activated partial thromboplastin time (TCA) over time.

Access publications on the manufacturer's website

Reference	CCH-10
Presentation	Kit
Format	80 x 1.0 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
CCH-10	Kit	80 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

CRYOcheck™ Heparin Control Certificate of analysis

Heparin is widely used in hospitals as an anticoagulant.
Unfractionated heparin is usually monitored using APTT and thrombin time tests.
Often, plasma samples are not identified as containing heparin and may be present as an unexpected contaminant.

- TCA ≈ 80 s Anti-Xa activity ≈ 0.3 IU / mL
- Values may vary depending on technique, instrument and reagent used.
- Flash freezing under nitrogen
- No bovine additives
- No reconstitution errorNo deterioration of plasmas linked to freeze-drying
- Plasmas verified negative for all tests required by the FDA
- Expiration date of 2 years from the date of manufacture with storage between -40 °C and -80 °C
- Packaging in plastic cryotubes suitable for all STA-R type microgodets

- Ready to use after 4 min at 37 °C
- Compact, color-coded boxes for easier identification in freezers

- 80 cryotubes x 1 mL of frozen plasma

CRYOcheck™ Abnormal 1 Control
CRYOcheck™ Abnormal 2 Control
CRYOcheck™ Low Fibrinogen Control
CRYOcheck™ Normal Reference Plasma
CRYOcheck™ Pooled Normal Plasma

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE FROZEN CALIBRATORS AND CONTROLS SCREENING TEST CONTROLS